No Data
No Data
Earnings Preview: BioLine Rx to Report Financial Results Pre-market on March 31
BioLineRx to Report 2024 Annual Results on March 31, 2025
Express News | BioLineRx Ltd Has Received A Notice Of Allowance For A U.S. Patent Titled "COMPOSITION OF BL-8040 (FOR THE TREATMENT OF CANCER)"
Express News | Trading Halt: Halt Status Updated at 8:55:00 AM ET: Quotation Resumption: News and Resumption Times
Express News | Trading Halt: Halted at 7:50:00 P.m. ET - Trading Halt: Halt News Pending
BioLine Rx To Carry Out 1-for-40 Reverse Stock Split On January 30th, 2025